{'fraction_non_alphanumeric': 0.025787965616045846, 'fraction_numerical': 0.0, 'mean_word_length': 5.852941176470588, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Infantile hemangioma: Efficacy of low‐dose propranolol and of intralesional bleomycin injection for propranolol non‐response

Infantile hemangioma (IH) is the most common form of benign childhood vascular tumor. Most resolve spontaneously, but treatment is recommended in patients who develop complication. Propranolol is recommended as the first‐line therapy, while the treatment in the case of non‐response to first‐line therapy depends on the clinical experiences of each center. The aim of this study was to investigate the efficacy of low‐dose propranolol in the treatment of IH, and the outcomes of percutaneous intralesional bleomycin injection (IBI) in patients unresponsive to propranolol.